Back
Corporate News
Sai Parenterals confirms no deviations in IPO proceeds utilization, raising Rs 2,850 million
11-Aug-2026, 07:42
Sai Parenterals Limited informed the Bombay Stock Exchange and National Stock Exchange that there were no deviations or variations in the utilization of proceeds from its Initial Public Offer (IPO) during the quarter ended June 30, 2026, as per Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had raised Rs 2,850 million through the IPO from March 24, 2026, to March 27, 2026.
Sai Parenterals Limited informed the Bombay Stock Exchange and National Stock Exchange that there were no deviations or variations in the utilization of proceeds from its Initial Public Offer (IPO) during the quarter ended June 30, 2026, as per Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had raised Rs 2,850 million through the IPO from March 24, 2026, to March 27, 2026.